• Users Online:85
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2012  |  Volume : 1  |  Issue : 3  |  Page : 143-149

Yield of contrast-enhanced power doppler endoscopic ultrasonography and strain ratio obtained by eus-elastography in the diagnosis of focal pancreatic solid lesions


1 Unité d`Exploration Médico-Chirurgicale Oncologique, Institut Paoli-Calmettes, France; Gastroenterology Department, University of the State of Rio de Janeiro and Federal University of Rio de Janeiro, Brazil
2 Biopathology Unit, Institut Paoli-Calmettes, France
3 Unité d`Exploration Médico-Chirurgicale Oncologique, Institut Paoli-Calmettes, France
4 Surgical Unit, Institut Paoli-Calmettes, France

Correspondence Address:
Fátima A.F Figueiredo
Unité d`Exploration Médico-Chirurgicale Oncologique, Institut Paoli-Calmettes, France; Gastroenterology Department, University of the State of Rio de Janeiro and Federal University of Rio de Janeiro, Brazil

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7178/eus.03.005

Rights and Permissions

Objective: Although endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is the gold standard for diagnosing pancreatic lesions, its negative predictive value is suboptimal. Our aim was to evaluate the yield of contrast-enhanced EUS (CED-EUS) and of strain ratio EUS-elastography (SR-E-EUS) for differentiating pancreatic solid lesions. Methods: Forty-seven patients (27 men, 20 women, 70 ± 11 years) were consecutively involved in this single-center, prospective study. They were submitted to EUS, SR-E-EUS, CED-EUS with Sonovue®, and EUS-FNA. The final diagnosis was based on the histological assessment of EUS-FNA and/or surgical specimens when available, and on follow-up of at least 6 months. Results: From the 47 focal pancreatic lesions included, 13 (28%) were benign and 34 (72%) malignant. Patients with malignancy were older (70 ± 11 vs. 61 ± 8, P = 0.003), and had larger lesions (34 ± 12 mm vs. 22 ± 11 mm, P = 0.03). Malignant lesions had higher SR-E-EUS (31 ± 32 vs. 8 ± 9, P = 0.001) and more hypovascular pattern (93% vs. 33%, P < 0.001). Logistic regression deter­mined that only hypovascularity (OR = 2.6, 95%CI: 1.5-130, P = 0.02) was independently predictive of malignancy. ROC analysis for SR-E-EUS yielded an optimal cutoff of 8 (AUC 0.91, 95%CI: 0.74-0.98) for the best power distinction for malignancy. There was no significant difference concerning sensitivity (79%, 90%, 93%) and specificity rates (85%, 75%, 67%) of EUS-FNA, SR-E-EUS, and CED-EUS, respectively. By analysis of the inconclusive EUS-FNA subset (9 patients, 19%), SR-E-EUS > 8 and hypovas­cularity showed sensitivity of 80% and 100%, and specificity of 67% and 67%, respectively. Conclusion: The clinical utility of CED-EUS and SR-E-EUS remains questionable. The accuracies of CED-EUS and SR-E-EUS are similar to EUS-FNA. Hypovascularity was independently predictive of malignancy. Patients with inconclusive EUS-FNA could benefit from CED-EUS due to the high sensitivity of hypovascularity for diagnosing malignancy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed945    
    Printed28    
    Emailed0    
    PDF Downloaded330    
    Comments [Add]    

Recommend this journal